Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...

The first new treatment for asthma attacks in 50 years has been developed, in a move that is being hailed as ‘game-changing’ ...

Every 30 seconds , someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

Researchers at King's College London have discovered a groundbreaking asthma treatment, Benralizumab, the first of its kind ...

Injection for asthma and COPD attacks shows a 30% reduction in the need for further treatment, outperforming steroid tablets.

A novel approach to addressing serious asthma and chronic obstructive pulmonary disease (COPD) attacks may prove to be a ...

AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the sta.

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab, the first new treatment for asthma and chronic obstructive pulmonary disease (COPD), is being called a ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...